ESR1 and breast carcinoma: Although mutations in the ER-α gene are relatively rare in primary breast cancers [2,3], Fuqua and colleagues recently described a point mutation in ER-α in one-third of typical breast hyperplasias [9], and also observed this mutation in a high percentage of breast tumors [10].